Spliceosome

Oct 23, 2019

Envisagenics wins another SBIR grant from the National Cancer Institute to enhance their AI/ML platform for Immunotherapy development

Sep 04, 2019

RNA Expert Dr. Phillip Sharp Joins as Advisor to Skyhawk Therapeutics

Sep 27, 2018

Computer Scientists at Worcester Polytechnic Institute Are Developing Tools to Probe the Molecular Basis of Complex Diseases

Jun 26, 2018

Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR* Technology Platform

Jan 23, 2018

Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression

Dec 11, 2017

Caris Life Sciences Identifies New Mechanism of Action for an Aptamer with Therapeutic Potential to Treat Non-Hodgkin Lymphoma

Nov 30, 2017

Envisagenics Closes $2.35M Seed Round and Launches SpliceCore Platform

Nov 28, 2017

Dynamk Capital Invests in Envisagenics to Advance AI Drug Discovery